Short answer
MERIT MEDICAL SYSTEMS INC (MMSI) filed its Q2 2026 10-Q quarterly report on Jul 30, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $419M (up 9.5% year over year) with net income of $39M.
Q2 2026 key financials · XBRL
- Revenue
- $419M
- +9.5% YoY · +9.7% QoQ
- Net income
- $39M
- +19.1% YoY · −5.3% QoQ
- Operating margin
- 14.4%
- Gross margin
- 51.4%
- EPS (diluted)
- $0.65
- +20.4% YoY · −4.4% QoQ
Source: XBRL data from the MERIT MEDICAL SYSTEMS INC (MMSI) Q2 2026 10-Q on SEC EDGAR. USD.
MERIT MEDICAL SYSTEMS INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q2 revenue $418.8M, up 10% YoY from $382.5M
- Gross margin 51.4% vs 48.2%; operating margin 14.4% vs 12.3%
- Best platform Endoscopy, $23.6M, up 28.5%; worst Procedural Solutions, $27.9M, down 11.9%
- Cash $450.9M vs $448.5M; operating cash flow $110.0M vs $123.9M
- 2026 capital spending expected at $80–$100M; tariff refund recovery remains uncertain
Risk Factors
- New geopolitical risk: United States–Israel–Iran conflict threatens energy supplies, supply chains, input costs, and customer spending
- Most material financial update: Revolving borrowing capacity increased to $700 million, potentially tightening leverage-covenant compliance
- Debt compliance risk: $747.5 million of 3.00% Convertible Notes mature February 1, 2029, with covenant breaches potentially accelerating repayment
- Liquidity risk: Secured credit agreement pledges substantially all assets, allowing lenders to foreclose after default
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MERIT MEDICAL SYSTEMS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.